Cipher Pharmaceuticals to present at Biotech Showcase™ 2013

Toronto Stock Exchange Symbol: DND 
MISSISSAUGA, ON, Jan. 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) 
(OTC: CPHMF), announced today that Larry Andrews, President and Chief 
Executive Officer, is presenting at Biotech Showcase™ 2013, which is being 
held in San Francisco at the Wyndham Parc 55 Hotel at Union Square. Mr. 
Andrews will provide a corporate update on Monday, January 7, 2013 at 1:45 PM 
PST in the Powell Room, followed immediately by Q&A breakout session in the 
Balboa Room. 
To learn more about Biotech Showcase™ 2013 please visit their website 
http://bit.ly/134duey 
Cipher's presentation will be available on their website www.cipherpharma.com. 
About Cipher Pharmaceuticals Inc. 
Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing specialty 
pharmaceutical company that commercializes novel formulations of successful, 
currently marketed molecules. Cipher's strategy is to in-license clearly 
differentiated products, advance them through the clinical development and 
regulatory approval stages, and out-license to international marketing 
partners. Cipher's first product is a fenofibrate formulation marketed in the 
United States as Lipofen®. Cipher's second product, an extended-release 
tramadol, is marketed in the United States as ConZip® and in Canada as 
Durela®. Cipher's third product, a novel formulation of the acne treatment 
isotretinoin, was approved by the FDA in May and was launched in the United 
States in Q4 2012 as Absorica™. The product was also recently approved by 
Health Canada and Cipher expects to launch it as Epuris™ in Canada in Q2 
2013. 
For more information, please visit www.cipherpharma.com. 
Craig Armitage Investor Relations The Equicom Group (416) 815-0700 ext 278 
(416)815-0080 fax carmitage@equicomgroup.com 
Larry Andrews President and CEO Cipher Pharmaceuticals (905) 602-5840 ext 324 
(905) 602-0628 fax landrews@cipherpharma.com 
SOURCE: Cipher Pharmaceuticals Inc. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/January2013/03/c3834.html 
CO: Cipher Pharmaceuticals Inc.
ST: Ontario
NI: MTC HEA SHOW NP  
-0- Jan/03/2013 14:00 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.